Accelerate treatment to patients
Achieve a faster, more efficient and compliant supply chain that reinvents operations and delivers results for patients.
Life sciences’ supply chains and operations are under pressure due to a rapid increase in drug complexity and discovery. Companies are struggling to juggle their traditional supply mix with new products for smaller patient groups, and silos delay treatment and impact care. Data-powered processes can optimize the links between supply chain & operations, R&D, regulatory, quality and commercial.
Is the average launch “delay” from FDA approval to first sale
Average revenue loss per launch due to the delay.
Is the average time it takes for a life sciences company to understand and react to a supply chain disruption
What you can do
Improve your productivity with the latest supply chain and operational technology. Quickly adopt product improvements and rapidly close less patient-centric variants.
Make your process faster and more efficient. Minimize waste, uncertainty and risk of non-compliance through continuous improvement, accelerated with data and AI.
A supply chain with robust, high-yield processes can speed up your R&D pipelines and diversification, helping you quickly scale your supply.
What’s trending in supply chain
Our leaders
Barry Heavey
Managing Director – Global Life Sciences Supply Chain & Manufacturing Lead
Carly Guenther
Managing Director – Strategy & Consulting, Supply Chain & Operations, Customer-Centric Supply Chain Lead